TRIMTECH Therapeutics
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
$47MSeed+
Role not disclosedCE
Cambridge Enterprise Ventures
Activity from announced rounds
Activity in this selectionBiotech
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $66.4M 3 disclosed · full round size, not this investor’s share